Traynor Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Traynor Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Sell	5,573 -1,009	-15%	-$51.2K	0.01%	270
2026 Q1	$346K	Sell	6,582 -79	-1%	-$4.64K	0.02%	218
2025 Q4	$414K	Sell	6,661 -567	-8%	-$35K	0.02%	211
2025 Q3	$434K	Sell	7,228 -184	-2%	-$11.3K	0.02%	197
2025 Q2	$463K	Sell	7,412 -211	-3%	-$12.7K	0.03%	143
2025 Q1	$459K	Sell	7,623 -316	-4%	-$19.6K	0.04%	127
2024 Q4	$463K	Sell	7,939 -2,363	-23%	-$140K	0.03%	149
2024 Q3	$610K	Sell	10,302 -53	-0.5%	-$3.03K	0.04%	130
2024 Q2	$580K	Sell	10,355 -1,822	-15%	-$102K	0.04%	129
2024 Q1	$713K	Sell	12,177 -2,179	-15%	-$123K	0.06%	119
2023 Q4	$775K	Sell	14,356 -4,508	-24%	-$220K	0.08%	105
2023 Q3	$915K	Sell	18,864 -1,847	-9%	-$98.2K	0.11%	89
2023 Q2	$1.17M	Sell	20,711 -13,494	-39%	-$743K	0.14%	77
2023 Q1	$1.85M	Sell	34,205 -33,949	-50%	-$1.81M	0.27%	58
2022 Q4	$3.58M	Sell	68,154 -14,217	-17%	-$721K	0.51%	41
2022 Q3	$3.89M	Sell	82,371 -5,936	-7%	-$308K	0.69%	32
2022 Q2	$4.45M	Sell	88,307 -28,158	-24%	-$1.53M	0.77%	32
2022 Q1	$7.1M	Sell	116,465 -7,184	-6%	-$428K	0.92%	25
2021 Q4	$8.14M	Sell	123,649 -3,941	-3%	-$252K	0.96%	23
2021 Q3	$8.01M	Sell	127,590 -9,240	-7%	-$590K	1.1%	19
2021 Q2	$8.36M	Sell	136,830 -3,660	-3%	-$212K	1.17%	20
2021 Q1	$7.74M	Sell	140,490 -1,416	-1%	-$78.5K	1.28%	19
2020 Q4	$7.74M	Buy	141,906 +102,762	+263%	+$5.37M	1.37%	15
2020 Q3	$2.05M	Buy	39,144 +84	+0.2%	+$4.07K	0.47%	45
2020 Q2	$1.72M	Buy	39,060 +20,712	+113%	+$885K	0.41%	46
2020 Q1	$689K	Buy	+18,348	New	+$773K	0.24%	58

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Traynor Capital Management's IHI Position: Q2 2026 in Review

Traynor Capital Management reduced its iShares US Medical Devices ETF (IHI) stake by 15% in Q2 2026, selling an estimated $51.2K and leaving 5,573 shares worth $275K. The position accounts for 0.01% of the portfolio, ranked #270.

Traynor Capital Management first reported a position in IHI in Q1 2020 and has held it in 26 quarters since. The position peaked at $8.36M in Q2 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Traynor Capital Management held 5,573 shares of iShares US Medical Devices ETF worth $275K as of Q2 2026.
Traynor Capital Management sold 1,009 iShares US Medical Devices ETF shares in Q2 2026, an estimated $51.2K.
iShares US Medical Devices ETF made up 0.01% of Traynor Capital Management's portfolio in Q2 2026, its #270 holding.
Traynor Capital Management first reported a position in iShares US Medical Devices ETF in Q1 2020 and has held it in 26 quarters since.
Traynor Capital Management's iShares US Medical Devices ETF position peaked at $8.36M in Q2 2021.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.